Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Vital Therapies Says Liver Device Shows Long-term Benefit in China Trial

publication date: Oct 14, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Vital Therapies, Inc. reported that its bioartifical liver support system, ELAD, produced a significant increase in transplant-free survival. A follow-up to the original China trial, conducted at the three-year point, shows that patients who survive in the short term enjoy extended survival. In a remarkable headline statistic, the follow-up concluded that median survival of the ELAD patients was at least 3 years, while the median survival for the control group was 37 days. More details....



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners